Novo Nordisk Lands Lexicon Pharma Obesity Drug With Potential to Pair With GLP-1s
Novo Nordisk has been on the hunt for differentiated obesity drugs that could complement its blockbuster GLP-1 agonist, Wegovy. It’s ...
Thursday, May 1, 2025
Tag: Novo
Novo Nordisk beats on Wegovy sales, expects slower 2025 growth
Danish drugmaker Novo Nordisk (NVO) reported fourth quarter and full year 2024 earnings Wednesday, beating Wall Street's expectations and bumping ...
Do We Need Humans in the Loop? A Novo Nordisk Exec Weighs In (Video)
Story follows beneath the quote from the extended video below “There’s very little need and this sounds cynical and I’m ...
Novo Nordisk Obesity Pill Flashes the Potential to Beat Wegovy in Weight Loss
An experimental Novo Nordisk obesity pill led to weight loss of 13.1% in a clinical trial, topping results posted in ...
Explore Israel's diverse narratives with The Israel Chronicle. Stay informed with unbiased reporting, insightful analysis, and comprehensive coverage of politics, culture, technology, and more. Discover the heartbeat of Israel through our trusted news platform.